Holen Sie sich die Stockscreener-App
6.54
4.31%
0.27
Handel nachbörslich:
6.43
-0.11
-1.68%
Cingulate Inc Aktie (CING) Neueste Nachrichten
Cingulate (NASDAQ: CING) vote on 19% share issuance and warrants - Stock Titan
CING Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Highlights: Can Cingulate Inc disrupt its industryDividend Hike & Daily Growth Stock Investment Tips - baoquankhu1.vn
CINGW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Buybacks Report: Does COLAR meet Warren Buffetts criteria2025 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Can Cingulate Inc. Equity Warrant maintain its current growth rate - mfd.ru
What drives Cingulate Inc.’s stock priceJuly 2025 Trade Ideas & Consistent Growth Equity Picks - mfd.ru
Investment deal brings well-known area entrepreneur to Cingulate board - The Business Journals
Activity Recap: What are analysts price targets for Cingulate Inc Equity WarrantQuarterly Growth Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug EndMonth: What are analysts price targets for Cingulate Inc Equity WarrantJuly 2025 Update & Accurate Trade Setup Notifications - baoquankhu1.vn
Volatility Watch: What are analysts price targets for Cingulate Inc Equity WarrantJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Cingulate Secures $12 Million PIPE to Advance CTx-1301 - The Globe and Mail
Cingulate Inc. announced that it has received $11.796254 million in funding - marketscreener.com
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Bitget
Cingulate appoints Jeff Hargroves to Board and key committees - TradingView
Investors lock up $12M to back Cingulate’s CTx-1301 launch - Stock Titan
Earnings Beat: What are analysts’ price targets for Cingulate Inc. Equity WarrantPortfolio Performance Report & Free Technical Confirmation Trade Alerts - mfd.ru
What are Cingulate Inc.’s recent SEC filings showingWeekly Trade Summary & Daily Momentum Trading Reports - mfd.ru
Is Cingulate Inc. Equity Warrant stock supported by innovation pipelineMarket Movers & Risk Managed Investment Signals - mfd.ru
Peter Werth Purchases 19,455 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Shane Schaffer Buys 6,809 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Cingulate (NASDAQ:CING) CFO Jennifer Callahan Purchases 4,864 Shares - MarketBeat
Growth Value: Is Cingulate Inc likely to announce a buybackWeekly Market Outlook & AI Powered Market Entry Ideas - baoquankhu1.vn
Weekly Recap: Is CDROW stock a good dividend stockWeekly Trading Summary & Safe Capital Growth Plans - baoquankhu1.vn
Cingulate Advances Capital Raise with Private Placement Financing - TipRanks
ADHD Drug Maker Cingulate Draws Investor Attention; Stock Up Over 60% In Seven Months - RTTNews
How Cingulate Inc. stock reacts to inflationary pressuresWeekly Risk Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Ideas Watch: Is Cingulate Inc in a long term uptrendQuarterly Investment Review & Weekly Momentum Picks - baoquankhu1.vn
Sentiment Watch: Should I average down on Cineverse Corp stockTrade Exit Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Cingulate Announces Private Placement and New Preferred Stock - The Globe and Mail
Cingulate Signs Multiple Material Agreements - TradingView
Cingulate Inc. announced that it expects to receive $12.011001 million in funding - marketscreener.com
What’s Cingulate Inc.’s historical returnTrading Volume Surges & The Smart Money Is Buying These Picks - bollywoodhelpline.com
Aug Patterns: What is the target price for Cingulate Inc Equity Warrant stockJuly 2025 Technicals & Community Verified Watchlist Alerts - baoquankhu1.vn
Is Cingulate Inc. stock attractive after correctionJuly 2025 Action & Accurate Buy Signal Alerts - bollywoodhelpline.com
Market Pulse: What is the target price for Cingulate Inc Equity Warrant stockExit Point & Short-Term Trading Alerts - baoquankhu1.vn
Cingulate (NASDAQ:CING) Trading 3.1% Higher – Should You Buy? - Defense World
Cingulate Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Cingulate increases at-the-market offering limit to $31.9 million By Investing.com - Investing.com Canada
Cingulate increases at-the-market offering limit to $31.9 million - Investing.com
Cingulate Inc. Increases Offering Price Under Sales Agreement - TradingView
Quarterly Recap: Is Cingulate Inc likely to announce a buybackJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
Analysis Recap: Why Cingulate Inc stock appeals to analystsForecast Cut & Real-Time Sentiment Analysis - Bộ Nội Vụ
Market Outlook: Will Cingulate Inc Equity Warrant stock remain a Wall Street favoriteJuly 2025 Reactions & High Win Rate Trade Alerts - Bộ Nội Vụ
Cingulate Inc Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing - TradingView — Track All Markets
Cingulate Retail Buzz Rises After FDA Greenlights Summer NDA Filing For ADHD Drug - MSN
Cingulate price target lowered to $16 from $17 at Roth Capital - MSN
Will Cingulate Inc. stock maintain dividend yieldColor and Style Update & trail grip notes for mixed terrain - ulpravda.ru
Why Cingulate Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
What analyst consensus says on Cingulate Inc. stockTake Profit & Safe Entry Zone Tips - Улправда
Market Moves: Will Cingulate Inc. stock gain from lower inflationBond Market & Daily Entry Point Trade Alerts - ulpravda.ru
Profit Recap: Is Cingulate Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - Улправда
Is Cingulate Inc. stock oversold or undervaluedQuarterly Trade Review & Low Drawdown Investment Ideas - Улправда
2.90%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):